• Ziqi Meng, Jiarui Wu, Xinkui Liu, Wei Zhou, Mengwei Ni, Shuyu Liu, Siyu Guo, Shanshan Jia, and Jingyuan Zhang.
• Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
• J. Int. Med. Res. 2020 Jul 1; 48 (7): 300060520910019.

ObjectiveThe objective was to identify potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma (HCC).MethodsGene expression profile datasets were downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) between HCC and normal samples were identified via an integrated analysis. A protein-protein interaction network was constructed and analyzed using the STRING database and Cytoscape software, and enrichment analyses were carried out through DAVID. Gene Expression Profiling Interactive Analysis and Kaplan-Meier plotter were used to determine expression and prognostic values of hub genes.ResultsWe identified 11 hub genes (CDK1, CCNB2, CDC20, CCNB1, TOP2A, CCNA2, MELK, PBK, TPX2, KIF20A, and AURKA) that might be closely related to the pathogenesis and prognosis of HCC. Enrichment analyses indicated that the DEGs were significantly enriched in metabolism-associated pathways, and hub genes and module 1 were highly associated with cell cycle pathway.ConclusionsIn this study, we identified key genes of HCC, which indicated directions for further research into diagnostic and prognostic biomarkers that could facilitate targeted molecular therapy for HCC.

21 keywords...

hide…